Opthomycetin Plus Eye Drop
By Opthomycetin Plus
Rx
5ml Eye Drop in a Packet

Composition
Chloramphenicol(0.5% w/v)

Manufacturer - Optho Remedies Pvt Ltd
Optho Remedies Pvt.Ltd. 28, MNNIT Industrial Estate, Teliarganj, Allahabad. Uttar Pradesh, India PIN - 211004

Expires on or after
October, 2025

liver
The safety of Opthomycetin Plus Eye Drop in relation to liver issues has not been established, as no interactions have been found. It is important to proceed with caution and consult with your doctor for proper guidance before using Opthomycetin Plus Eye Drop, especially if you have any liver-related concerns or conditions. Your doctor will be able to provide personalized advice based on your specific medical history and needs.

kidney
No interaction or established effects on the kidney have been found with Opthomycetin Plus Eye Drop. If you have concerns about using this product due to kidney issues, consult with your doctor for proper guidance before using Opthomycetin Plus Eye Drop.

alcohol
No interaction has been found or established between Opthomycetin Plus Eye Drop and alcohol. It is advisable to consult your doctor when consuming alcohol with Opthomycetin Plus Eye Drop.

driving
After using Opthomycetin Plus Eye Drop, your vision may be blurry briefly. Avoid driving until your vision returns to normal.

pregnancy
Opthomycetin Plus Eye Drop may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing it. Please consult your doctor for guidance.

breastfeeding
Opthomycetin Plus Eye Drop is not considered safe during breastfeeding. Limited data indicates potential transfer of the drug into breastmilk, posing a risk to the baby.
Habit Forming | No |
Chemical Class | Amphenicols |
Therapeutic Class | OTOLOGICALS |
Action Class | Chloramphenicol |
₹24.22
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024